Monte Rosa Therapeutics, Inc.GLUENASDAQ
Loading
Asset Growth Under PressureDecelerating
Percentile Rank43
Studio
Year-over-Year Change

Year-over-year total asset growth rate

Percentile
P43
Within normal range
vs 2Y Ago
-0.1x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
PeriodValue
Q4 2025-2.43%
Q3 202527.88%
Q2 2025-8.55%
Q1 2025-10.38%
Q4 202439.24%
Q3 2024-8.44%
Q2 202429.00%
Q1 2024-12.18%
Q4 202320.49%
Q3 2023-9.52%
Q2 2023-9.84%
Q1 2023-9.74%
Q4 2022-4.25%
Q3 2022-2.04%
Q2 20225.51%
Q1 2022-5.55%
Q4 2021-4.61%
Q3 20214.09%
Q2 2021104.28%
Q1 2021265.76%
Q4 20200.00%
Q3 20200.00%
Q2 20200.00%
Q1 20200.00%